Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
暂无分享,去创建一个
Shan Jiang | Lynda Chin | Qiuyun Wang | Andrea Viale | Nora S. Sanchez | Giulio Draetta | Gerald C. Chu | Ronald A. DePinho | Alexei Protopopov | Yi Zhong | Baoli Hu | Haoqiang Ying | L. Chin | A. Protopopov | R. DePinho | Hong’ai Xia | S. Hua | Baoli Hu | Eliot Fletcher-Sananikone | Y. A. Wang | Chang-Jiun Wu | G. Chu | Jianhua Zhang | Randy L. Johnson | Huamin Wang | A. Sadanandam | Shan Jiang | Carol S. Lim | T. Heffernan | G. Draetta | Changli Wu | Y. Zhong | H. Ying | A. Viale | A. Kapoor | Q. Chang | Huamin Wang | Anguraj Sadanandam | Jianhua Zhang | Sujun Hua | Wantong Yao | W. Yao | Alison Liewen | Qiuyun Wang | R. Al-Khalil | Gillian I. Horwitz | P. Pettazzoni | Chang-Jiun Wu | Qing Chang | Avnish Kapoor | Alison Liewen | Ramsey Al-Khalil | Hongai Xia | Eliot Fletcher-Sananikone | Carol Lim | Piergiorgio Pettazzoni | Nora Sanchez | Timothy Heffernan | Y. Alan Wang
[1] P. Northcott,et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. , 2009, Genes & development.
[2] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[3] Anne E Carpenter,et al. A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.
[4] Patricia Greninger,et al. A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. , 2009, Cancer cell.
[5] Martin Vingron,et al. TransFind—predicting transcriptional regulators for gene sets , 2010, Nucleic Acids Res..
[6] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[7] Li Li,et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.
[8] S. Dry,et al. PTEN loss accelerates KrasG12D-induced pancreatic cancer development. , 2010, Cancer research.
[9] N. Jenkins,et al. Response and Resistance to MEK Inhibition in Leukaemias Initiated by Hyperactive Ras , 2009, Nature.
[10] C. Galbán,et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.
[11] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Sasaki,et al. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling , 2008, Development.
[14] I. Weinstein. Addiction to Oncogenes--the Achilles Heal of Cancer , 2002, Science.
[15] Joseph Rosenbluh,et al. KRAS and YAP1 Converge to Regulate EMT and Tumor Survival , 2014, Cell.
[16] Gerald C. Chu,et al. P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation , 2008, Nature.
[17] Jun O. Liu,et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. , 2012, Genes & development.
[18] Leah B. Honor,et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy , 2012, Proceedings of the National Academy of Sciences.
[19] R. DePinho,et al. Genetics and biology of pancreatic ductal adenocarcinoma. , 2006, Genes & development.
[20] W. Kaelin,et al. The cellular effects of E2F overexpression. , 1996, Current topics in microbiology and immunology.
[21] O. Kirak,et al. Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation , 2011, Cell.
[22] B. Stanger. Quit your YAPing: a new target for cancer therapy. , 2012, Genes & development.
[23] A. Pobbati,et al. Emerging roles of TEAD transcription factors and its coactivators in cancers , 2013, Cancer biology & therapy.
[24] Andrew Menzies,et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.
[25] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[26] L. Trusolino,et al. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils , 2011, EMBO molecular medicine.
[27] J. Inazawa,et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. , 2011, Carcinogenesis.
[28] N. Sarvetnick,et al. Hippo Signaling Regulates Pancreas Development through Inactivation of Yap , 2012, Molecular and Cellular Biology.
[29] Jiandie D. Lin,et al. TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.
[30] R. DePinho,et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.
[31] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[32] R. Bernards,et al. Understanding resistance to targeted cancer drugs through loss of function genetic screens. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[33] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[34] A. Penzo-Méndez,et al. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. , 2013, Gastroenterology.
[35] Manuel Serrano,et al. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. , 2003, Cancer cell.
[36] E. Olson,et al. Hippo pathway effector Yap promotes cardiac regeneration , 2013, Proceedings of the National Academy of Sciences.
[37] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[38] C. Tamm,et al. Regulation of mouse embryonic stem cell self-renewal by a Yes–YAP–TEAD2 signaling pathway downstream of LIF , 2011, Journal of Cell Science.
[39] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[40] N. López-Bigas,et al. Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit. , 2011, Genes & development.
[41] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[42] Laura M. Heiser,et al. A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma. , 2012, Cancer discovery.
[43] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[44] M. Barbacid,et al. Genetically engineered mouse models of pancreatic adenocarcinoma , 2013, Molecular oncology.
[45] J. Fridlyand,et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.
[46] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[47] F. Gage,et al. YAP regulates neural progenitor cell number via the TEA domain transcription factor. , 2008, Genes & development.
[48] P. Spellman,et al. Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.
[49] D. Bar-Sagi,et al. RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.
[50] David M. Thomas,et al. The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.
[51] Ralph Weissleder,et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[52] Prasenjit Dey,et al. Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.
[53] M. Wigler,et al. Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach , 2006, Cell.
[54] Bin Zhao,et al. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal , 2011, Nature Cell Biology.
[55] R. Rad,et al. Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer. , 2013, Cancer cell.
[56] H. Pasolli,et al. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin , 2011, Proceedings of the National Academy of Sciences.
[57] Frank McCormick,et al. Cancer therapy based on oncogene addiction , 2011, Journal of surgical oncology.